Franklin M Berger has bought stock on 11 days since Sep 2016

Director at Retension Pharmaceuticals, Inc., and 6 other companies

SEC CIK 0001273885 · Filings on SEC.gov ↗

$6.0MBought

$1.6MSold

Oct 13Last buy

Franklin M Berger's record

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Companies

Every filing

15 filings since Sep 2016, newest first

RTSNBuy

Retension Pharmaceuticals, Inc.

Director

$120KOct 13

AVIRBuy

Atea Pharmaceuticals, Inc.

Director

$81K+6.0%Jan 17

EPIXSell

Essa Pharma Inc.

Director

$729K−29.0%Jan 5

AVIRSell

Atea Pharmaceuticals, Inc.

Director

$215K−5.0%Nov 15

KZRBuy

Kezar Life Sciences, Inc.

Director

$1.3M+10.0%Mar 22

EPIXBuy

Essa Pharma Inc.

Director

$1.5M+6.0%Mar 4

AVIRBuy

Atea Pharmaceuticals, Inc.

Director

$1.0M+5.0%Nov 3

KZRBuy

Kezar Life Sciences, Inc.

Director

$314K+21.0%Feb 5

FPRXSell

Five Prime Therapeutics, Inc.

Director

$317K−94.0%Dec 4

PTIBuy

Proteostasis Therapeutics, Inc.

Director

$270K+15.0%Oct 26

PTIBuy

Proteostasis Therapeutics, Inc.

Director

$300K+29.0%Dec 19

IMDZBuy

Immune Design Corp.

Director

$114K+50.0%Nov 1

IMDZBuy

Immune Design Corp.

Director

$107K+100.0%Oct 26

IMDZSell

Immune Design Corp.

Director

$327K−67.0%Dec 20

PTIBuy

Proteostasis Therapeutics, Inc.

Director

$900K+71.0%Sep 15

Filings come from SEC EDGAR. Not investment advice.